Ardena Capabilities Update August 2026: Nanoparticles

Nanomedicines are transforming precision medicine, but their development requires specialized expertise across formulation, analytics, manufacturing, and regulatory strategy. This webinar explores an integrated approach to nanomedicine development, covering lipid-based nanoparticles, polymeric systems, metal and metal-oxide nanoparticles, and bioconjugates. Attendees will learn how scalable manufacturing techniques, including flow chemistry and tangential flow filtration, can support the transition from early proof of concept through clinical production and commercialization.

View key considerations for analytical characterization, phase-appropriate method validation, GMP manufacturing, and regulatory readiness. Particular attention is given to overcoming common scale-up challenges, ensuring product quality, and maintaining development efficiency for both emerging biotech innovators and established pharmaceutical organizations. Through real-world experience gained across more than 100 nanomedicine programs, this session provides practical insights into developing complex nanoparticle-based therapeutics and advancing them confidently from preclinical research to clinical and commercial success.